Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value?
A lower stock price doesn't eliminate investment risk.
Overview
Few stocks have destroyed as much shareholder value as Canopy Growth (NASDAQ: CGC). Since its 2018 peak, shares of the cannabis producer have lost more than 99% of its value as the industry struggled with oversupply, regulatory delays, and years of unprofitable growth. That kind of collapse naturally raises a question: Is this finally a buying opportunity?
To be fair, Canopy Growth is a much healthier company now than it was a few years ago. Fiscal 2026 revenue increased 6% to $200.4 million, while cannabis revenue climbed 15%. Canadian medical cannabis revenue reached a record level, international cannabis sales rebounded sharply in the fourth quarter, and management continues targeting positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) during fiscal 2027. The balance sheet has also improved.
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.